Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03858936
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CTB | N-2-THIOPHEN-2-YL-ACETAMIDE BORONIC ACID | A,B | 1FSW | 0.73 |  |
PNM | OPEN FORM - PENICILLIN G | A | 1GHP | 0.7 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1PWC | 0.7 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1IYQ | 0.7 | |
| PNM | OPEN FORM - PENICILLIN G | A | 1FQG | 0.7 | |
| PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2J8Y | 0.7 | |
| PNM | OPEN FORM - PENICILLIN G | A,B,C,D | 2JBF | 0.7 | |
| PNM | OPEN FORM - PENICILLIN G | A | 2EX8 | 0.7 | |
VG3 | N-[(1S,2R)-1-benzyl-3-{[(1S)-2- (cyclohexylamino)-1-methyl-2-oxoethyl]amino}- 2-hydroxypropyl]-3-(pentylsulfonyl)benzamide | A | 2VIY | 0.71 | |
CLS | CEPHALOTHIN | A,B | 1KVL | 0.75 | |
CS3 | S-[3-OXO-3-(2-THIENYL)PROPYL]-L- CYSTEINE | A | 2OQW | 0.74 | |
CED | 5-METHYL-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-3,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A | 1GHM | 0.79 | |
160 | 3-(3-{2-[(5-METHANESULFONYL-THIOPHENE- 2-CARBONYL)-AMINO]-ETHYLDISULFANYLMETHYL}- BENZENESULFONYLAMINO)-4-OXO-PENTANOIC ACID | A,B | 1NMQ | 0.7 | |
CEP | CEPHALOTHIN GROUP | A | 1CEG | 0.77 | |
| CEP | CEPHALOTHIN GROUP | A | 1IYP | 0.77 | |
NCF | (2R)-2-{(1R)-2-OXO-1-[(2-THIENYLACETYL)AMINO]ETHYL}- 5,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | A,B,C,D | 1W8Y | 0.75 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1JK3 | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1MMB | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 2RJQ | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1RM8 | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 2J83 | 0.71 | |
| BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 1DTH | 0.71 | |
THN | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYLENE-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.74 | |
KCP | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYL-3,6-DIHYDRO-2H- [1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.81 | |
CEO | 5-METHYLENE-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVM | 0.74 | |
CFX | CEFOXITIN | A,B | 1YMX | 0.72 | |
| CFX | CEFOXITIN | A,B | 1I2W | 0.72 | |